U.S. flag

An official website of the United States government

NM_139343.3(BIN1):c.461G>A (p.Arg154Gln) AND Myopathy, centronuclear, 2

Germline classification:
Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:
Jan 19, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:

Allele description [Variation Report for NM_139343.3(BIN1):c.461G>A (p.Arg154Gln)]

NM_139343.3(BIN1):c.461G>A (p.Arg154Gln)

BIN1:bridging integrator 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Genomic location:
Preferred name:
NM_139343.3(BIN1):c.461G>A (p.Arg154Gln)
  • NC_000002.12:g.127068982C>T
  • NG_012042.1:g.43307G>A
  • NM_001320632.2:c.461G>A
  • NM_001320633.2:c.461G>A
  • NM_001320634.1:c.389G>A
  • NM_001320640.2:c.461G>A
  • NM_001320641.2:c.461G>A
  • NM_001320642.1:c.380G>A
  • NM_004305.4:c.461G>A
  • NM_139343.3:c.461G>AMANE SELECT
  • NM_139344.3:c.461G>A
  • NM_139345.3:c.461G>A
  • NM_139346.3:c.461G>A
  • NM_139347.3:c.461G>A
  • NM_139348.3:c.461G>A
  • NM_139349.3:c.461G>A
  • NM_139350.3:c.461G>A
  • NM_139351.3:c.461G>A
  • NP_001307561.1:p.Arg154Gln
  • NP_001307562.1:p.Arg154Gln
  • NP_001307563.1:p.Arg130Gln
  • NP_001307569.1:p.Arg154Gln
  • NP_001307570.1:p.Arg154Gln
  • NP_001307571.1:p.Arg127Gln
  • NP_004296.1:p.Arg154Gln
  • NP_647593.1:p.Arg154Gln
  • NP_647594.1:p.Arg154Gln
  • NP_647595.1:p.Arg154Gln
  • NP_647596.1:p.Arg154Gln
  • NP_647597.1:p.Arg154Gln
  • NP_647598.1:p.Arg154Gln
  • NP_647599.1:p.Arg154Gln
  • NP_647600.1:p.Arg154Gln
  • NP_647601.1:p.Arg154Gln
  • LRG_873t1:c.461G>A
  • LRG_873:g.43307G>A
  • LRG_873p1:p.Arg154Gln
  • NC_000002.11:g.127826558C>T
  • NM_004305.3:c.461G>A
  • NM_139343.2:c.461G>A
Protein change:
R127Q; ARG154GLN
OMIM: 601248.0004; dbSNP: rs267606681
NCBI 1000 Genomes Browser:
Molecular consequence:
  • NM_001320632.2:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001320633.2:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001320634.1:c.389G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001320640.2:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001320641.2:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001320642.1:c.380G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_004305.4:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139343.3:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139344.3:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139345.3:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139346.3:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139347.3:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139348.3:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139349.3:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139350.3:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139351.3:c.461G>A - missense variant - [Sequence Ontology: SO:0001583]


Myopathy, centronuclear, 2 (CNM2)
MONDO: MONDO:0009709; MedGen: C0410204; Orphanet: 169186; OMIM: 255200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
no assertion criteria provided
(Feb 9, 2010)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV000930065SIB Swiss Institute of Bioinformatics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Jan 8, 2019)

PubMed (3)
[See all records that cite these PMIDs]

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Jan 19, 2024)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedcuration



Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]

Phenotype of a patient with recessive centronuclear myopathy and a novel BIN1 mutation.

Claeys KG, Maisonobe T, Böhm J, Laporte J, Hezode M, Romero NB, Brochier G, Bitoun M, Carlier RY, Stojkovic T.

Neurology. 2010 Feb 9;74(6):519-21. doi: 10.1212/WNL.0b013e3181cef7f9. No abstract available.

PubMed [citation]
See all PubMed Citations (5)

Details of each submission

From OMIM, SCV000029008.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)


In a 21-year-old Moroccan man with autosomal recessive centronuclear myopathy (CNM2; 255200) beginning in childhood, Claeys et al. (2010) identified a homozygous 461G-A transition in exon 6 of the BIN1 gene, resulting in an arg154-to-gln (R154Q) substitution in a conserved residue in the BAR domain. The mutation was not present in 280 normal controls. The patient had diffuse muscle weakness and atrophy and mild mental retardation.

OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From SIB Swiss Institute of Bioinformatics, SCV000930065.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (3)


This variant is interpreted as a Likely pathogenic for Myopathy, centronuclear, 2 autosomal recessive. The following ACMG Tag(s) were applied: PM2 : Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PS3 : Well-established functional studies show a deleterious effect (PMID:24755653). PP3 : Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PM1 : Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation.

OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV001375361.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)


This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 154 of the BIN1 protein (p.Arg154Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with centronuclear myopathy (PMID: 20142620). ClinVar contains an entry for this variant (Variation ID: 8300). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BIN1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects BIN1 function (PMID: 24755653, 25262827). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024